Editorial Board — Medscape HIV/AIDS
Board Members
- John G. Bartlett, MD
- Johns Hopkins University School of Medicine
The Johns Hopkins Hospital
Baltimore, Maryland
- Johns Hopkins University School of Medicine
- Susan P. Buchbinder, MD
- University of California - San Francisco
Department of Public Health
City and County of San Francisco, California
- University of California - San Francisco
- Myron S. Cohen, MD
- University of North Carolina (UNC) - Chapel Hill
Institute for Global Health and Infectious Diseases
UNC Hospitals
Chapel Hill, North Carolina
- University of North Carolina (UNC) - Chapel Hill
- Salim S. Abdool Karim, MBChB, PhD
- University of KwaZulu-Natal
Nelson Mandela School of Medicine
Durban, South Africa
- University of KwaZulu-Natal
- Carl A. Kirton, DNP, ANP-BC, ACRN
- New York University College of Nursing
New York, NY
Lincoln Hospital and Mental Health Center
Bronx, New York
- New York University College of Nursing
- Veronica Miller, PhD
- George Washington School of Public Health
Forum for Collaborative HIV Research
School of Public Health, UC Washington Center
Washington, DC
- George Washington School of Public Health
- Paul E. Sax, MD
- Harvard Medical School
Brigham and Women's Hospital
Boston, Massachusetts
- Harvard Medical School
- Rochelle P. Walensky, MD, MPH
- Harvard Medical School
Massachusetts General & Brigham and Women's Hospitals
Boston, Massachusetts
- Harvard Medical School
Board Member Details
John G. Bartlett, MD
Professor of Medicine, Johns Hopkins University School of Medicine; Director, HIV Care Program, The Johns Hopkins Hospital, Baltimore, Maryland
John G. Bartlett, MD, has disclosed no relevant financial relationships.
Susan P. Buchbinder, MD
Associate Clinical Professor, Department of Medicine, Epidemiology & Biostatistics, University of California - San Francisco; Director, HIV Research Section, AIDS Office, Department of Public Health, City and County of San Francisco, California
Susan P. Buchbinder, MD, has disclosed no relevant financial relationships.
Myron S. Cohen, MD
J. Herbert Bate Distinguished Professor, Department of Medicine, University of North Carolina (UNC) - Chapel Hill; Institute for Global Health and Infectious Diseases; Chief, Division of Clinical Infectious Diseases, UNC Hospitals, Chapel Hill, North Carolina
Myron S. Cohen, MD, has disclosed no relevant financial relationships.
Salim S. Abdool Karim, MBChB, PhD
Pro Vice Chancellor of Research, University of KwaZulu-Natal, Nelson Mandela School of Medicine, Durban, South Africa
Disclosure: Salim S. Abdool Karim, MBChB, PhD, has disclosed the following relevant financial relationships:
Received income in an amount equal to or greater than $250 from: Merck &Co., Inc.
Applied for patent with: Gilead Sciences, Inc.
Carl A. Kirton, DNP, ANP-BC, ACRN
Clinical Associate Professor of Nursing, New York University College of Nursing, New York, New York; Chief Nursing Officer, Lincoln Hospital and Mental Health Center, Bronx, New York
Carl A. Kirton, DNP, ANP-BC, ACRN, has disclosed no relevant financial relationships.
Veronica Miller, PhD
Research Professor, George Washington School of Public Health; Executive Director, Forum for Collaborative HIV Research; Visiting Professor, School of Public Health, UC Washington Center, Washington, DC
Veronica Miller, PhD, has disclosed the following relevant financial relationships:
Served as an advisor for: Bristol-Myers Squibb Company; Roche
Received research grants from: The Forum for Collaborative HIV Research has received unrestricted grants from the following companies: National Institutes of Health; Centers for Disease Control and Prevention; charitable foundations, as well as the pharmaceutical and diagnostic industry (including Abbott Laboratories; Alere; Anadys; BD Biosciences; Boehringer Ingelheim Pharmaceuticals, Inc.; bioMerieux; Bristol-Myers Squibb Company; Gilead Sciences, Inc.; GlaxoSmithKline; Idenix Pharmaceuticals; InterMune, Inc.; Kaiser Permanente; Merck & Co., Inc.; Monogram Biosciences; Novartis Pharmaceuticals Corporation; Orasure Technologies; Pharmasset; Roche; Serono; Tibotec, Inc.; Vertex; ViiV).
Paul E. Sax, MD
Associate Professor of Medicine, Harvard Medical School; Clinical Director, Division of Infectious Diseases and HIV Program, Brigham and Women's Hospital, Boston, Massachusetts
Paul E. Sax, MD, has disclosed the following relevant financial relationships:
Served as a consultant for: Abbott Laboratories; Bristol-Myers Squibb Company; Gilead Sciences, Inc.; GlaxoSmithKline; Merck & Co., Inc.; ViiV; Tibotec, Inc.
Received research grants from: Gilead Sciences, Inc.; Merck & Co., Inc.; Tibotec, Inc.; ViiV
Rochelle P. Walensky, MD, MPH
Associate Professor of Medicine, Department of Medicine, Division of Infectious Diseases, Harvard Medical School; Associate Director, Program in HIV Epidemiology and Outcomes Research, Department of Medicine, Division of Infectious Diseases, Massachusetts General & Brigham and Women's Hospitals, Boston, Massachusetts
Rochelle P. Walensky, MD, MPH, has disclosed the following relevant financial relationships:
Spouse is a consultant and SAB member to Aileron Therapeutics